An Anti-CD3 Single-chain Immunotoxin with a Truncated Diphtheria Toxin Avoids Inhibition by Pre-existing Antibodies in Human Blood

This publication has 21 references indexed in Scilit:

• Efficacy of direct intratumoral therapy with targeted protein toxins for solid human gliomas in nude mice
  Journal of Neurosurgery, 1994
• Anti-T cell immunotoxins: a look at post-endocytotic receptor-mediated routing
  Journal of Controlled Release, 1993
• Characterization of single-chain antibody (sFv)-toxin fusion proteins produced in vitro in rabbit reticulocyte lysate.
  Journal of Biological Chemistry, 1993
• In vivo T-cell ablation by a holo-immunotoxin directed at human CD3.
  Proceedings of the National Academy of Sciences, 1992
• Development of humanized bispecific antibodies reactive with cytotoxic lymphocytes and tumor cells overexpressing the HER2 protooncogene.
  The Journal of Experimental Medicine, 1992
• [4] Construction of single-chain Fv derivatives of monoclonal antibodies and their production in Escherichia coli
  Published by Elsevier ,1991
• Diphtheria-related peptide hormone gene fusions: A molecular genetic approach to chimeric toxin development
  Published by Springer Nature ,1988
• Immunotoxins for in Vivo Therapy: Where Are We?
  Annals of the New York Academy of Sciences, 1987
• Diphtheria toxin receptor binding domain substitution with interleukin-2: genetic construction and properties of a diphtheria toxin-related interleukin-2 fusion protein
  Protein Engineering, Design and Selection, 1987
• The amino-acid sequence of two non-toxic mutants of diphtheria toxin: CRM45 and CRM197
  Nucleic Acids Research, 1984